Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05353790 · ClinicalTrials.gov registry record · NA
Dietary Exchanges With Avocado and Mango in Pre-diabetes
A NA study of PreDiabetes and Cognitive Change, sponsored by Clinical Nutrition Research Center, Illinois Institute of Technology.
- Completed
- Registry status
- NA
- Development phase
- 82
- Enrollment target
- 1
- Study location
NCT05353790: Completed NA study of PreDiabetes and Cognitive Change, sponsored by Clinical Nutrition Research Center, Illinois Institute of Technology.
NCT05353790 is a NA study of PreDiabetes and Cognitive Change that has completed, run by Clinical Nutrition Research Center, Illinois Institute of Technology. The registered enrollment target is 82 participants, below the 701-participant average among 149 other PreDiabetes trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05353790, a NA study of PreDiabetes and Cognitive Change, has completed, sponsored by Clinical Nutrition Research Center, Illinois Institute of Technology.
- COMPLETED
- Registry status
- NA
- Development phase
- 82 participants
- Enrollment target
- 1
- Study location
Study Summary
The research is designed as a randomized, 2-arm, parallel, controlled, human clinical trial to investigate the effects of avocado and mango consumption for 8 weeks on indices of macro- and micro- vascular function in individuals with prediabetes. FMD of the brachial artery, pulse wave velocity (PWV), central blood pressure (cBP), and Optical Coherence Tomography Angiography (OCTA) of the eye will be used for vascular assessments. The research plan will also explore cognitive and kidney function benefits of regular avocado and mango intake using specified cognitive tasks and kidney function biomarkers
Primary Outcome
Macro-vascular assessment by Ultrasonography
Conditions Studied
Interventions
- OTHER Meals + snacks: control
- OTHER Meals + snacks: Avocado mango
Study Locations (1)
Illinois
- Clinical Nutrition Research Center - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 82 participants |
| Start Date | 2021-10-11 |
| Est. Completion | 2025-12-20 |
| Phase | NA |
What the finished NCT05353790 record still lists
NCT05353790 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 82 participants, a relatively small participant target, below the 701-participant average among 149 other PreDiabetes trials with a reported enrollment target (88% lower).
The record links to 5 conditions, with PreDiabetes appearing as the primary indexed condition, and to 2 interventions - of which Meals + snacks: control is the first listed.
NCT05353790 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT05353790 about?
NCT05353790 is a clinical study titled "Dietary Exchanges With Avocado and Mango in Pre-diabetes". The research is designed as a randomized, 2-arm, parallel, controlled, human clinical trial to investigate the effects of avocado and mango consumption for 8 weeks on indices of macro- and micro- vascular function in individuals with prediabetes. FMD of the brachial artery, pulse wave velocity (PWV)...
What is the current status of trial NCT05353790?
This trial is currently completed. It is a NA study. The enrollment target is 82 participants. The study started on 2021-10-11. Estimated completion is 2025-12-20.
What conditions does trial NCT05353790 study?
This clinical trial studies the following conditions: PreDiabetes, Cognitive Change, Vascular Stiffness, Vascular Dilation, Retinal Vascular.
What interventions are being tested in trial NCT05353790?
The interventions under investigation include: Meals + snacks: control (OTHER), Meals + snacks: Avocado mango (OTHER).
Who is sponsoring clinical trial NCT05353790?
This trial is sponsored by Clinical Nutrition Research Center, Illinois Institute of Technology, which has 59 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05353790 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for PreDiabetes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05353790's enrollment target sits among peer trials
82 70th of 149 higher than 80 of 149 other PreDiabetes trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other PreDiabetes trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Longitudinal Multi-Omic Profiles to Reveal Mechanisms of Obesity-Mediated Insulin Resistance
RECRUITING · NA
-
Black Impact: The Mechanisms Underlying Psychosocial Stress Reduction in a Cardiovascular Health Intervention
RECRUITING · NA
-
Diabetes Clinical Decision Support
RECRUITING · NA
-
Food as Medicine for HIV and Diabetes
RECRUITING · NA
-
Cleaner Air for Lower Cardiometabolic Risk
RECRUITING · NA
-
Strategies for Implementing a Postpartum Lifestyle Intervention in WIC Clinics
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03319901 · 82 participants · Phase 1
Venetoclax and Chemotherapy as Frontline Therapy in Older Patients and Patients With Relapsed/Refractory ALL
- NCT03493425 · 82 participants · Phase 2
Chemotherapy Before Surgery and Radiation Therapy or Surgery and Radiation Therapy Alone in Treating Patients With Nasal and Paranasal Sinus Cancer That Can Be Removed by Surgery
- NCT04105270 · 82 participants · Phase 2
RMT in Combination With Durvalumab + Chemo in Untreated Adenocarcinoma NSCLC. A Randomized Double Blind Phase II Trial
- NCT04428658 · 82 participants · NA
Randomized Trial of Supplemental Synchronous and Asynchronous Telehealth to Improve Glycemic Control for Pediatric Patients With Type 1 Diabetes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI